Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term

This study was supported by grants from the National Institutes of Health: 1R01DA059152-01 (IM and JO), 7R01AI145910-05S1(IM), TL1TR001997 (HT) and pilot funding from the University of Kentucky, including the Clinical and Translational Science Substance Use Disorder pilot grant 3210003238 (IM and JO). This research was indirectly supported by the Kentucky Opioid Response Effort (KORE) via Substance Abuse and Mental Health Services Administration (SAMHSA) Grants, H79TI081704, H79TI083283, as well as the data management system that is hosted by UK with grant support from NIH CTSA UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Kentucky.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2026-03-17
DOI
https://doi.org/10.1016/j.ebiom.2026.106214
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term

Heather True, Brianna M. Doratt, Delphine C. Malherbe, Cynthia Cockerham et al.
EBioMedicine
Pregnancy and Medication Impact
article

Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term

Heather True, Brianna M. Doratt, Delphine C. Malherbe, Cynthia Cockerham, John O'Brien, Ilhem Messaoudi, Zachary M. Reynolds, Sheridan B. Wagner
article en

Abstract

This study was supported by grants from the National Institutes of Health: 1R01DA059152-01 (IM and JO), 7R01AI145910-05S1(IM), TL1TR001997 (HT) and pilot funding from the University of Kentucky, including the Clinical and Translational Science Substance Use Disorder pilot grant 3210003238 (IM and JO). This research was indirectly supported by the Kentucky Opioid Response Effort (KORE) via Substance Abuse and Mental Health Services Administration (SAMHSA) Grants, H79TI081704, H79TI083283, as well as the data management system that is hosted by UK with grant support from NIH CTSA UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Kentucky.

EBioMedicineVol. 126
University of Kentucky (US)
Good health and well-being
Openalex Percentile: Top 23%
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.